NCT03715933 2026-03-18
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
Phase 1 Recruiting
Inhibrx Biosciences, Inc
IGM Biosciences, Inc.
Children's Oncology Group
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center